Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study.
about
Breast cancer brain metastases: the last frontierEmerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancerSystemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma.Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada - Clinical Trials Group (NCIC-CTG).Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors.Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study.Temozolomide added to whole brain radiotherapy in patients with multiple brain metastases of non-small-cell lung cancer: a multicentric Austrian phase II study.The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics.Current approaches to the treatment of metastatic brain tumours.Progress in the biological understanding and management of breast cancer-associated central nervous system metastases.Profound prevention of experimental brain metastases of breast cancer by temozolomide in an MGMT-dependent manner.Integration of chemotherapy into current treatment strategies for brain metastases from solid tumors.Surgery of recurrent brain metastases: retrospective analysis of 67 patients.Treatment of Breast Cancer Brain Metastases.Chemotherapy and targeted molecular therapies for brain metastases.Breast cancer brain metastases: new directions in systemic therapyCNS metastasis in primary breast cancer.Temozolomide for treatment of brain metastases: A review of 21 clinical trials.The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guidelineBreast cancer brain metastases: a review of the literature and a current multidisciplinary management guideline.Combining stereotactic radiosurgery and systemic therapy for brain metastases: a potential role for temozolomideTreatment of brain metastases from HER-2-positive breast cancer: current status and new concepts.Brain metastases in breast cancer.Chemotherapy and biological treatment options in breast cancer patients with brain metastasis: an update.Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG).Challenges in the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer with brain metastases.Phosphorylation of AKT induced by phosphorylated Hsp27 confers the apoptosis-resistance in t-AUCB-treated glioblastoma cells in vitro.Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases.Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.Quality of life and efficacy of temozolomide combined with whole-brain radiotherapy in patients with brain metastases from non-small-cell lung cancer.
P2860
Q26775663-E3D68EED-E877-43AB-AFC0-D8B028CBC09EQ26824799-C56178CF-F467-4273-91C2-A2149D0AD801Q30239901-B165DC3D-559A-4AE6-AD2C-36661A616AA5Q33370672-9D7C5148-6736-4CDA-A5DD-8139B367B6FEQ33375710-3A2CDCF4-EEB4-4122-99CF-A367EE3E4660Q33386298-D7E4B4DE-4E57-4F67-B526-F8FB31E19E2CQ33409478-2DED1589-6781-4D76-AE03-8B42926DD0B2Q33599167-E6BB555B-12F0-4343-B848-04399AFD7A57Q33696559-D84AE765-61B7-4A8D-A9F7-09B96A83D180Q33777436-3C3EE5C2-F5BE-4544-AF90-0932AE3E7043Q33909294-BF07E2A0-D802-4D23-85D3-198389F0C413Q34872345-0D53A397-78F9-435F-BDC2-8559277476F7Q34891770-CC17EBCD-10AA-4C84-8A68-80EDA8458283Q36057858-1C71B8E7-209A-469B-91FA-85B159435C29Q36641504-0355A1CE-E54B-49F1-97B3-CEFECAB24908Q36822500-6C2DD99A-A648-49C8-8C71-9C36A1FBF651Q37004668-2BCB41B2-26B8-4A7B-8544-40FBEDAB6004Q37576025-FD687F76-C8E3-48BA-85B0-65FDEEE62B79Q37643544-DFECB345-EE77-48CA-8CD0-844F652D7405Q37698300-2DF4C7F0-06B8-4936-BE65-002A8E565598Q38036217-B99E95E5-3A21-495D-B245-31C12AB57EB6Q38155202-FFAE516A-622E-48AC-8364-BEC53459096AQ38168924-63D34E72-F3FE-4C4E-88FB-70B058379584Q38230553-8540170D-25AF-4548-9CA6-141B15D5CBC8Q38688750-A6326385-4D58-4218-81A1-F18B5DC9B23CQ38792519-B707EA0C-7E7D-4280-B4C5-FAAE956542D9Q38958544-26798F7B-3F08-4F78-8365-AFDD33058D56Q54118354-5881E392-AFAF-4AAB-AFDF-2BB179908D24Q55128184-65AF0FFE-35DE-439C-AFC2-A3423B560C16Q55518797-8A6DE5B9-2A4B-4D0A-B2CB-F6E08C7E4942
P2860
Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Temozolomide (TMZ) combined wi ...... Group (HeCOG) Phase II study.
@ast
Temozolomide (TMZ) combined wi ...... Group (HeCOG) Phase II study.
@en
type
label
Temozolomide (TMZ) combined wi ...... Group (HeCOG) Phase II study.
@ast
Temozolomide (TMZ) combined wi ...... Group (HeCOG) Phase II study.
@en
prefLabel
Temozolomide (TMZ) combined wi ...... Group (HeCOG) Phase II study.
@ast
Temozolomide (TMZ) combined wi ...... Group (HeCOG) Phase II study.
@en
P2093
P1476
Temozolomide (TMZ) combined wi ...... Group (HeCOG) Phase II study.
@en
P2093
Aristotelis Bamias
Christos Christodoulou
Dimitrios Bafaloukos
George Klouvas
Gerassimos Aravantinos
Helen Linardou
Hellenic Cooperative Oncology Group
Maria Carina
P2888
P356
10.1007/S11060-004-9176-0
P577
2005-01-01T00:00:00Z
P6179
1012108006